NDC codes

382549 NDC codes with hospital pricing data in the network.

• NDC 00069023420 — Propofol (69 hospitals, 3,126–4,215 samples)
• NDC 43598054821 — PROPOFOL 10 MG/ML INTRAVENOUS EMULSION (89 hospitals, 3,126–4,215 samples)
• NDC 00409469950 — PROPOFOL 10 MG/ML INTRAVENOUS EMULSION (71 hospitals, 3,126–4,215 samples)
• NDC 16714097720 — Propofol (50 hospitals, 3,126–4,215 samples)
• NDC 00641619520 — PROPOFOL IV EMUL 1000 MG/100ML (10 MG/ML),PROPOFOL IV EMUL 500 MG/50ML (10 MG/ML),PROPOFOL IV EMUL 200 MG/20ML (10 MG/ML),PROPOFOL IV EMUL PREFILLED SYRINGE 200 MG/20ML (10 MG/ML) (38 hospitals, 3,126–4,215 samples)
• NDC 00641619501 — PROPOFOL 10 MG/ML INTRAVENOUS EMULSION (37 hospitals, 3,126–4,215 samples)
• NDC 00591213655 — PROPOFOL IV EMUL 1000 MG/100ML (10 MG/ML),PROPOFOL IV EMUL 500 MG/50ML (10 MG/ML),PROPOFOL IV EMUL 200 MG/20ML (10 MG/ML),PROPOFOL IV EMUL PREFILLED SYRINGE 200 MG/20ML (10 MG/ML) (26 hospitals, 3,126–4,215 samples)
• NDC 16714069010 — Propofol: 10 Vial In 1 Carton (16714-690-10) / 100 Ml In 1 Vial (16714-690-01) (43 hospitals, 3,126–4,215 samples)
• NDC 36000028325 — FUROSEMIDE 20 MG INJ (282 hospitals, 784–4,213 samples)
• NDC 70092-1093-37 — FENTANYL (PF) 10 MCG/ML IN 0.9 % SODIUM CHLORIDE INTRAVENOUS (86 hospitals, 3,851–4,211 samples)
• NDC 00245-5317-01 — POTASSIUM CHLORIDE ER 10 MEQ TABLET,EXTENDED RELEASE(PART/CRYST) (46 hospitals, 3,948–4,209 samples)
• NDC 60505614304 — CEFAZOLIN 10 GRAM SOLUTION FOR INJECTION (104 hospitals, 717–4,209 samples)
• NDC 00944-2700-13 — GAMMAGARD LIQUID 10 % INJECTION SOLUTION (28 hospitals, 4,200 samples)
• NDC 00409130431 — Hydromorphone Hydrochloride: 10 Cartridge In 1 Carton (0409-1304-31) / 1 Ml In 1 Cartridge (0409-1304-03) (48 hospitals, 1,565–4,193 samples)
• NDC 50419034410 — iopromide 300 mg iodine/mL Soln 100 mL VIAL (74 hospitals, 4,139–4,193 samples)
• NDC 00065-0092-65 — FLUORESCEIN 500 MG/5 ML (10 %) INTRAVENOUS SOLUTION (81 hospitals, 4,021–4,192 samples)
• NDC 00121-0868-16 — NYSTATIN 100,000 UNIT/ML ORAL SUSPENSION (35 hospitals, 4,021–4,192 samples)
• NDC 407141361 — IOHEXOL 300 MG/ML (OMNIPAQUE-300) IJ SOLN (86 hospitals, 3,948–4,191 samples)
• NDC 00270-1315-45 — IOPAMIDOL 300 MG IODINE /ML (61 %) IV SOLN (25 hospitals, 4,035–4,188 samples)
• NDC 00004-1963-01 — CEFTRIAXONE 500MG PWD INJ (25 hospitals, 3,179–4,187 samples)
• NDC 00409272031 — HEPARIN (PORCINE) 1/000 UNIT/ML IJ SOLN (114 hospitals, 521–4,184 samples)
• NDC 00904-7193-61 — FAMOTIDINE 20 MG TABLET (84 hospitals, 4,012–4,183 samples)
• NDC 00409477610 — LIDOCAINE (PF) 15 MG/ML (1.5 %) INJECTION SOLUTION (50 hospitals, 3,171–4,179 samples)
• NDC 09990239600 — LACTULOSE 10 GRAM/15 ML ORAL SOLUTION (3 hospitals, 4,034–4,178 samples)
• NDC 51754100001 — MAGNESIUM SULFATE 50 % IJ SOLN (85 hospitals, 1,873–4,177 samples)
• NDC 25021-0700-01 — KETOROLAC 15 MG/ML INJECTION SOLUTION (48 hospitals, 2,151–4,167 samples)
• NDC 00409189001 — MORPHINE PF 2 MG/ML SOLUTION (274 hospitals, 1,226–4,160 samples)
• NDC 00409000125 — MIDAZOLAM HCL INJ 2 MG/2ML (BASE EQUIVALENT),MIDAZOLAM HCL INJ 10 MG/10ML (BASE EQUIVALENT),MIDAZOLAM HCL INJ 5 MG/5ML (BASE EQUIVALENT),MIDAZOLAM HCL INJ PF 2 MG/2ML (BASE EQUIVALENT),MIDAZOLAM HCL INJ PF 5 MG/5ML (BASE EQUIVALENT),MIDAZOLAM INJ SOLN PREFILLED SYRINGE 2 MG/2ML,MIDAZOLAM IV SOLN PREFILLED SYRINGE 2 MG/2ML,MIDAZOLAM INJ SOLN PREFILLED SYRINGE 3 MG/3ML,MIDAZOLAM INJ SOLN PREFILLED SYRINGE 5 MG/5ML (105 hospitals, 2,783–4,160 samples)
• NDC 00143-9787-10 — ENALAPRILAT 1.25 MG/ML INTRAVENOUS SOLUTION (131 hospitals, 3,525–4,155 samples)
• NDC 68982-0850-04 — IG OCTAGAM10%20GM/2DLIVJW (104 hospitals, 4,135–4,153 samples)
• NDC 63323048301 — LIDOCAINE 20 MG/ML (2 %)-EPINEPHRINE 1:100000 INJECTION SOLUTION (75 hospitals, 2,705–4,145 samples)
• NDC 70092-1613-79 — MORP PF 30MG/30ML PCA SYR (29 hospitals, 3,772–4,141 samples)
• NDC 42192-0608-16 — GABAPENTIN 250 MG/5ML PO SOLN (97 hospitals, 3,891–4,134 samples)
• NDC 68982-0850-03 — IMMUN GLOBG(IGG)-MALT-IGA OV50 10 % IV SOLN (109 hospitals, 4,122 samples)
• NDC 63323010602 — Magnesium Sulfate (210 hospitals, 2,011–4,117 samples)
• NDC 00641606001 — Midazolam Hcl Oral/Rectal/Inj 5 Mg/Ml (Base Equivalent) (152 hospitals, 1,618–4,111 samples)
• NDC 00409672941 — MAGNESIUM SULFATE 4 GM/100ML IV SOLN (50 hospitals, 1,580–4,109 samples)
• NDC 00409672911 — Magnesium Sulfate (81 hospitals, 1,590–4,101 samples)
• NDC 00409259603 — MIDAZOLAM 5 MG/ML INJECTION SOLUTION (74 hospitals, 1,831–4,099 samples)
• NDC 67457055300 — MAGNESIUM SULFATE IN WATER 2 GRAM/50 ML (4 %) IV PGBK (190 hospitals, 1,864–4,087 samples)
• NDC 36000-0306-60 — ACETAMINOPHEN 1,000 MG/100 ML (10 MG/ML) INTRAVENOUS SOLUTION (65 hospitals, 3,667–4,081 samples)
• NDC 17271-0710-07 — LACTATED RINGERS INTRAVENOUS SOLUTION (24 hospitals, 3,498–4,074 samples)
• NDC 00338011702 — Lactated Ringer's (98 hospitals, 2,947–4,072 samples)
• NDC 51754425003 — EPHEDRINE SULFATE 25 MG/5ML IV (WRAPPED) (91 hospitals, 2,395–4,069 samples)
• NDC 68084025401 — hydrOXYzine 25 mg tab (88 hospitals, 3,888–4,068 samples)
• NDC 00143-9334-01 — BUPIVACAINE (PF) 0.5 % (5 MG/ML) INJECTION SOLUTION (59 hospitals, 3,300–4,065 samples)
• NDC 59746017310 — 59746-0173-10 - predniSONE 10 mg Tab (58 hospitals, 3,272–4,055 samples)
• NDC 00054472831 — predniSONE 5 mg tablet 1,000 each Bottle (28 hospitals, 3,272–4,055 samples)
• NDC 00591544310 — Prednisone: 1000 Tablet In 1 Bottle (0591-5443-10) (27 hospitals, 3,272–4,055 samples)
• NDC 00603533732 — PREDNISONE TAB 5 MG (40 hospitals, 3,272–4,055 samples)